CVS Health Corporation Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 100.43B | 105.69B | 102.87B | 98.92B | 94.59B | 97.71B | 95.43B | 91.23B |
| Cost of Goods Sold | 84.80B | 92.13B | 89.06B | 85.32B | 80.19B | 84.81B | 82.87B | 77.85B |
| Gross Profit | 15.62B | 13.57B | 13.81B | 13.59B | 14.40B | 12.90B | 12.56B | 13.38B |
| R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 10.94B | 11.46B | 17.01B | 11.21B | 11.02B | 10.53B | 11.73B | 10.34B |
| Operating Income | 4.68B | 2.11B | -3.21B | 2.38B | 3.37B | 2.37B | 832.0M | 3.04B |
| Other Income / Gains | -742.0M | -758.0M | -275.0M | -734.0M | -757.0M | -242.0M | -727.0M | -708.0M |
| Net Income | 2.94B | 2.94B | -3.98B | 1.02B | 1.78B | 1.64B | 87.0M | 1.77B |
| EPS (Diluted) | 2.31 | 2.32 | -3.13 | 0.81 | 1.41 | 1.31 | 0.069 | 1.41 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.156 | 0.128 | 0.134 | 0.137 | 0.152 | 0.132 | 0.132 | 0.147 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses | 10.94B | 11.46B | 17.01B | 11.21B | 11.02B | 10.53B | 11.73B | 10.34B |
| Cost And Expenses | 95.75B | 103.58B | 106.08B | 96.53B | 91.21B | 95.34B | 94.60B | 88.19B |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 774.0M | 787.0M | 784.0M | 763.0M | 785.0M | 758.0M | 752.0M | 732.0M |
| Depreciation And Amortization | 1.11B | 1.15B | 1.13B | 1.17B | 1.15B | 1.15B | 1.16B | 1.15B |
| Ebitda | 5.83B | 3.29B | -1.56B | 3.58B | 4.56B | 4.03B | 2.02B | 4.22B |
| Ebitdaratio | 0.058 | 0.031 | -0.015 | 0.036 | 0.048 | 0.041 | 0.021 | 0.046 |
| Operating Income Ratio | 0.047 | 0.02 | -0.031 | 0.024 | 0.036 | 0.024 | 0.009 | 0.033 |
| Income Before Tax | 3.94B | 1.35B | -3.48B | 1.65B | 2.62B | 2.13B | 105.0M | 2.34B |
| Income Before Tax Ratio | 0.039 | 0.013 | -0.034 | 0.017 | 0.028 | 0.022 | 0.001 | 0.026 |
| Income Tax Expense | 995.0M | -1.57B | 508.0M | 634.0M | 835.0M | 503.0M | 34.0M | 569.0M |
| Net Income Ratio | 0.029 | 0.028 | -0.039 | 0.01 | 0.019 | 0.017 | 0.001 | 0.019 |
| Epsdiluted | 2.30 | 2.30 | -3.13 | 0.80 | 1.41 | 1.30 | 0.069 | 1.41 |
| Weighted Average Shs Out | 1.27B | 1.27B | 1.27B | 1.27B | 1.26B | 1.26B | 1.26B | 1.26B |
| Weighted Average Shs Out Dil | 1.28B | 1.28B | 1.27B | 1.27B | 1.26B | 1.26B | 1.26B | 1.26B |